Panion & Bf Biotech Inc. (TPE:1760)
Taiwan · Delayed Price · Currency is TWD 63.60
-0.20 (-0.31%)
Jan 22, 2026, 11:33 AM CST
Panion & Bf Biotech Market Cap
Panion & Bf Biotech has a market cap or net worth of 5.47 billion as of January 21, 2026. Its market cap has decreased by -21.62% in one year.
Market Cap
5.47B
Enterprise Value
5.73B
Revenue
2.04B
Ranking
n/a
PE Ratio
31.43
Stock Price
63.60
Market Cap Chart
Since September 30, 2004, Panion & Bf Biotech's market cap has increased from 534.45M to 5.47B, an increase of 923.50%. That is a compound annual growth rate of 11.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 5.47B | 1.27% |
| Dec 31, 2025 | 5.40B | -23.26% |
| Dec 31, 2024 | 7.04B | -26.70% |
| Dec 29, 2023 | 9.60B | -37.43% |
| Dec 30, 2022 | 15.35B | 138.03% |
| Dec 30, 2021 | 6.45B | -1.27% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| OBI Pharma | 6.65B |
| Savior Lifetec | 6.27B |
| CHO Pharma | 6.09B |
| Steminent Biotherapeutics | 6.00B |
| Pharmosa Biopharm | 5.93B |
| Sinphar Pharmaceutical | 5.88B |
| Locus Cell | 5.78B |
| UnicoCell Biomed | 5.33B |